Skip to main content
VCbacked
Log inGet Started

Odyssey Therapeutics

Boston, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

$25.0M raised
May 2026
Post-IPO Equity
BiotechnologyHealth CareOncologyTherapeutics

Top Investors

TPGGeneral CatalystLightspeed Venture PartnersGreatPoint VenturesCatalio Capital Management

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Odyssey Therapeutics

How much funding has Odyssey Therapeutics raised?
Odyssey Therapeutics has raised $25.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Who are Odyssey Therapeutics's investors?
Odyssey Therapeutics's investors include TPG, General Catalyst, Lightspeed Venture Partners, GreatPoint Ventures, Catalio Capital Management.
Where is Odyssey Therapeutics headquartered?
Odyssey Therapeutics is headquartered in Boston, United States.
What does Odyssey Therapeutics do?
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
What stage is Odyssey Therapeutics at?
Odyssey Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Odyssey Therapeutics — Funding & Investors." VCBacked, May 8, 2026, https://www.vcbacked.co/company/odyssey-therapeutics. Accessed July 5, 2026.
APA
VCBacked. (2026). Odyssey Therapeutics — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/odyssey-therapeutics
Wikipedia (cite web)
{{cite web |title=Odyssey Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/odyssey-therapeutics |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K